Effect of Magnesium Injection on Foetal Development by Günther, T. et al.
Günther, Vormann and Merker: Bffect of magnesium injection on foetal development 473
J. Clin. Chem. Clin. Biochcm.
Vol. 22, 1984, pp. 473-478
Effect of Magnesium Injection on Foetal Development
By T. Günther, J. Vormann
Institut für Molekularbiologie und Biochemie, Freie Universität Berlin and
H. 7. Merker
Institut für Embryonalpharmakologie, Freie Universität Berlin
(Received November 25, 1983/March 27, 1984)
Summary: Pregnant rats were subcutaneously injected twice daily with JL5 ml 150 mmol/1 MgCh beginning at
day 5 of gestation. By this treatment development of foetal liver and pancreas was enhanced. In the foetal
liver, there was a precocious glycogenolysis combined with a precocious development of the smooth endoplas-
mic reticulum (ER) and an irregulär arrangement of the rough ER. In the pancreas, the development of
secretory granules was enhanced.
In alizarin red-stained and cleared specimens, the foetal skeleton was less calcified. The injected Mg2* re-
mained extracellular. Altered hormonal secretion and/or an altered activity of the regulatory enzymes of
glycogen metabolism induced by the increased extracellular Mg2+ concentration are discussed äs possible
mechanisms for enhanced foetal liver development.
Wirkung von Magnesium-Injektionen auf die Foetalentwicklung
Zusammenfassung: Schwangeren Ratten wurde zweimal täglich 1,5 ml 150 mmol/1 MgCh-Lösung, beginnend
vom Tag 5 der Gravidität, subcutan injiziert. Durch diese Behandlung erfolgte in der foetalen Leber eine
vorzeitige Glykogenolyse, verbunden mit einer vorzeitigen Entwicklung des glatten endoplasmatischen Re-
tikulums (ER) und einer unregelmäßigen Anordnung des rauhen ER.
Im Pankreas war die Entwicklung von exkretorischen Vesikeln beschleunigt.
Das foetäle Skelett 'war iri geringerem Maße calcifiziert.
Das injizierte Mg2+ verblieb im Extrazellulärraum.
Als Mechanismus für die beschleunigte foetäle Leber-Entwicklung wurden eine geänderte Hormonsekretion
und/oder veränderte Aktivitäten der regulatorischen Enzyme des Glykogenstoffwechsels, ausgelöst durch die
erhöhte extrazelluläre Mg2+-Kortzentration, angenommen.
Introduction
In tocolytic therapy with ß-agonists 20.5% of the
newborns exhibit hypotrophy according to the chos-
en score. When, during tocolysis, patients were sup-
plemented with Mg2+ (15—20 mmol/day), only
8.8% of the newborns were hypotrophic, i.e. the
same frequency of occurence äs in normal pregnancy
(8-11%) (l).
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When pregnant rats were injected daily with MgSO4
(150 mg/kg body weight) from day 5 of pregnancy,
the foetal livers at term 'were well developed with
morphofunctional features closely resembling those
of the adult organs (2).
From these observations, it seems that chronic Mg2*
supplementation during pregnancy may enhance
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foetal development. We therefore investigated foetal
development, to find at which stage of pregnancy it is
enhanced by Mg2*, which foetal Organs are con-
cerned, and the nature of the biochemical mecha-
nism responsible for the effect.
Materials and Methods
Wistar rats weighing 200 g were used in the experiments. The rats
were maintained under a 12-hour light-dark cycle and at a
temperature of about 20 °C. Virgin females were mated from
8-10 a. m. and impregnated females were identified by the pres-
ence of copulatory plugs. This day was designated äs day 0 of
gestation. The animals were fed with Altromin (Altromin, Lage,
FRG) (Mg2+ content: 83 mmol/kg, Ca2+ content: 220 mmol/kg)
and tap water (Mg2* content: 0.5 mmol/1) ad libitum.
Morpho logy
Some of the pregnant rats were subcutaneously injected twice per
day at 9 a.m. and 4 p.m. with 1.5 ml 150 mmol/I MgCb. At day
10, 11, 12, 13, 15, 17, 19, 20 and 21 of pregnancy, two Mg2+-in-
jected and one control rat were killed. Up to day 13 the number of
somites was calculated. Foetuses from day 10 to 17 were fixed in
toto in 30 g/l paraformaldehyde and 30 g/l glutaraldehyde in 0.2
mol/1 cacodylate buffer pH 7.2 for electron microscopy and in
35 g/l formaldehyde for light microscopy and alizarin red-stain-
ing. From day 19-21, separated tissues were fixed for electron
microscopy and histology. For electron microscopy, postfixation
was performed in 10 g/l OsC>4 in cacodylate buffer pH 7.2, fol-
lowed by dehydration in ethanol, embedding in Mikropal, section-
ing with Reichert and LKB microtomes, and contrasting in uranyl
acetate/lead citrate. Electron microscopy was performed with
Zeiss EM 10 and Siemens 101. For histology, slices were stained
in haematoxilin-eosin (HE).
For detection of skeletal development, foetuses from day 19 to 21
were fixed in formalin, stained with alizarin red, cleared in NaOH,
and stored in glycerol.
Mg2+ metabol ism
To determine whether MgCb injected into the mothers is taken
up by foetal tissues, pregnant rats were injected 7 times every 4
hours with 1.5 ml 150 mmol/1 MgCh beginning from day 18 at 9
a. m. At day 19, the rats were killed at various times after the last
injection.
Foetal blood, heart, liver and maternal blood were taken under
pentobarbital (Nembutal®) anesthesia (50 mg/kg). For experi-
mental details see I.e. (3).
In a second experiment, after laparotomy in pentobarbital anes-
thesia, half of the foetuses in each pregnant rat were s.c. injected
with 75 150 mmol/1 MgCh. After two hours, foetal blood,
heart, liver, and maternal blood were taken.
Foetal hearts and livers were freeze-dried. For deterfnifiation of
electrolyte content, the freeze-dried tissues were ashed overnight
in a Low Temperature Asher (Tracerlab), dissolved in 0.1 mol/1
HC1 containing l g/l La3+. After dilution with H^O, containing
l g/l La3+, Mg2+ and Ca2+ were measured in an atomic absorp-
tion spectrophotometer (Perkin-Elmer, model 300). After dilu-
tion with 30 mmol/1 LiCl, Na+ and K+ were measured in a flame
photometer (Beckman). All Solutions were made with Millipore
water. For details see 1. c. (3).
Results
Growth rate
When pregnant rats, fed with the normal Mg2* rieh
food, were injected with MgCla from day 5, the
number of the somites in the foetuses at day 10, 11,
12 and 13 was unchanged (tab. 1). Also the weight
of the foetuses at day 20 and 21 was unaltered
(tab. 2). Therefore, growth rate was not affected un-
der our conditions of Mg2+ supplementatiori.
Tab. l. Number of somites of foetuses frorn MgCh-injected and























Tab. 2. Weight (g) of the foetuses from MgCh-injected and un-















The deposition of glycogen, usually beginning at day
17, was the same in both foetal groups. Höwever,
beginning at day 19, the glycogen content was lower
in the Mg2+-treated foetuses than in the controls.
From day 20 to 21, in the Mg2+-treated foetuses, the
glycogen content decreased, whereas in the cpritrols,
glycogen increased further. Fröm this result one can
conclude that the lower glycogen content in the
Mg2+-treated group is caused by glycogenolysis. Pa-
rallel with the reduction of glycogen content, there
was an increase in the amount of smootfo endoplas-
mic reticulüm (ER). The rough ER, normally or-
dered in parallel was in part irregularly arranged and
in contact with mitochondria. Siitiilär behaviour was
seen when the biosynthesis of mitochondria was en-
ftanced (4). Gell membranes, mitochondria and nu-
cleus of the hepatocytes were not affected by Mg2+-
treatment (figs. l, 2):
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Fig. 1.
A Part of a liver cell from a control rat foetus day 19 with
large glycogen-filled areas (*), mitochondria (m) and
cavities of the rough endoplasmic reticulum, packed in
a parallel manner (χ), χ 25000.
B Part of a liver cell from a MgCb-treated rat foetus, day
19. No glycogen deposits and an irregul r course of the
cavities of the rough ER (x). m = mitochondria.
x 25000.
Other cell types of the foetal liver were not signifi-
cantly changed. The accelerated development by
Mg2+-injection did not reach the adult state; adult
liver still has less glycogen and more smooth ER
than foetal liver after Mg2+-treatment.
Adrenals
As glucocorticoid hormones play a permissive role in
glycogen synthesis in foetal liver (5), the develop-
ment of the adrenals was electronmicroscopically in-
vestigated. However, there were no significant qual-
itative morphological differences in the development
of foetal adrenals from untreated and MgCl2-treated
pregnant rats.
Pancreas
As insulin and glucagon are involved in the regula-
tion of glycogen metabolism and s the ratio insulin/
glucagon is perinatally changed (6), the behaviour of
pancreatic islets was investigated. The foetal pan-
creatic islets from MgC^-treated pregnant rats
showed no changes in the normal pattern of develop-
ment, and significant morphological differences be-
tween the control foetuses and those from MgCl2-
treated mothers were not observed.
However, the development of the excretory part of
the pancreas was enhanced by MgCla-treatment. Be-
ginning from day 17 and more expressed at later
stages, the excretory cells from MgCl2-treated foe-
tuses contain more ER and excretory vesicles than
those from untreated controls. Some material was al-
ready excreted into the ductus (fig. 3).
Fig. 2. Part of a rat liver cell from a day 20 foetus after treatment
with MgCh. Residues of glycogen (*). Increase of smooth
endoplasmic reticulum (φ), m = mitochondria, N = nu-
cleus. Most of the cavities of the rough endoplasmic retic-
ulum are isolated (x). x 25000.
Lung, kidney
In the lungs and kidneys of foetuses from MgCb-in-
jected and non-injected pregnant rats, no significant
morphological alterations could be seen by light and
electron microscopy.
Skeleton
In the foetuses of MgC^-injected mothers, the patt-
ern of the skeleton was not altered but the minerali-
zation of all bones was reduced in Alizarin red-
stained and cleared specimens. This could be seen
best in the tail. As the bones of the tail are the last to
be mineralized, the number of tail vertebrae was
lower than in the controls (fig. 4).
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Fig. 3.
A Exocrine pancreas cell from a control rat foetus, day
19, with numerous cavities of the rough ER (x) and
free ribosomes. Note the absence of secretory granules.
N = nucleus. x 7500.
B Exocrine pancreas cell from an MgCh-treated rat
foetus with numerous cavities of the rough ER (x) and
secretory granules (^3). Nucleus (N) with large nucleoli
(*). x 7500.
This result is in agreement with in-vitro mineraliza-
tion experiments. 45Ca2+ incorporation in bone was
also reduced by competition with Mg2+, when the
extracellular Mg2+ concentration was increased (7).
Mg2"1" me tabo l i sm
In pregnant rats, subcutaneously injected every 4
hours with 1.5ml 150 mmol/1 MgCl2, the serum
Mg2+ concentration 30 min p.i. was increased to 3.1
mmol/1 and dropped rapidly to 1.2 mmol/1 within 4
hours after injection (fig. 5). This subsequent fall is
due to excretion and to the adsorption of Mg2"1" to
bone.
Serum Mg2"1" concentration in the corresponding foe-
tal rats only changed between 2.1 and 1.7 mmol/1.
Foetal serum Mg2+ in this experiment was therefore







Fig. 4. The caudal portions of a control (C) and an MgCh-treated
(T) rat foetus, day 19, alizarin reo%staining and cleared.
Note the lower alizarin red uptake ( ]) or absence (*) of









Fig. 5. Foetal (x-x) and maternal (O-O) serum Mg2-f concen-
tration at various times after the last s.c. injection of
1.5 ml 150 mmol/1 MgCh into pregnant rats (day 19 of
gestation). For details see Methods. ® = foetaj and ® =
maternal serum Mg2+ concentration of untreated rats.
24 to 28 hours if compared with uninjected rats. Un-
der these conditions, the Na+, K+, Ca2+ and Mg2+
contents in foetal hearts and livers were not signifi-
cantly changed (tab. 3).
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Tab. 3. Mg2+, Ca2+, Na+ and K* content in foetal hearts and
livers.
Control: foetuses from non-injected pregnant rats. Mg2+
treated foetuses from pregnant rats s. c. injected 7 times
from day 18 to 19 with 1.5 ml 150 mmol/1 MgCh. Foetal
tissues of each rat were pooled. n = number of pregnant
rats in each group. Mean ± SEM.
Mg2+ Ca2+ Na+ K+



























Therefore, in a second expefiment, foetal serum
Mg2+ was increased further by direct subcutaneous
injection of 75 150 mmol/1 MgCl2 into the foe-
tuses. Two hours p. i. foetal serum Mg2+ was in-
creased from 1.38 ± 0.06 mmol/1 in the control foe-
tuses to 4.81 ± 0.20 mmol/1 in the MgCl2-injected
foetuses. At the same time the tissue Mg2"1" of MgCb-
injected fetuses was slightly increased: In the hearts
from 43.3 ±1.4 mmol/kg dry weight to 47.0 ± 0.9
mmol/kg dry weight, and in the livers from 45.7 ±
0.6 mmol/kg dry weight to 50.1 ± 0.4 mmol/kg dry
weight. (Values are given äs means ± SEM, n = 6).
The other electrolytes were not changed in the foe-
tuses 2 hours after s.c. injection of MgCl2 (not
shown). When extracelliilar and intracellular Mg2"1"
was calculated from the extracellular flüid volume by
means of the Na"1" space and serum Mg2"1" concentra-
tions, no sigiuficant increase of intracellular Mg2"1" in
heart and liver was föund (not shown). Therefore,
the smäll increase of Mg2* content in the tissues of
the MgC^^injected foetuses was caused by the in-
crease in extracellular Mg2* concentration.
Discussion
The most significant result of our experiments was
the accelerated development of the foetal livers by
MgCk-treatment of their mothers.
From our morphological results, the decrease of
glycogen and the development of smooth ER seem
to be combined. As the mechanism for the enhanced
development of foetal liver by Mg2+ treatment, an
increase of the intracellular concentration of Mg2+ or
other electrolytes can be excluded, becaüse the cel-
lular electrolyte contents were not changed by the
increase in extracellular Mg2+ concentration. This al-
so holds for the drastic increase in foetal serum Mg2+
concentration by direct s.c. injection into the foe-
tuses. Therefore, the precocious decrease of liver
glycogen combined with the precocious development
of ER may be produced by other mechanisms. These
may be an altered foetal hormone secretion and/or
an altered activity of regulatory enzymes of glycogen
metabolism.
As the onset and early deposition of glycogen occurs
at the normal time point in both groups (day 17), the
permissive role of glucocorticoid hormones seems to
be unaltered by maternal Mg24" treatment, in agree-
ment with the absence of any morphological altera-
tion of adrenal development.
From a consideration of the biochemical actions of
insulin and glucagon, a reduction of the insulin/glu-
cagon ratio could explain the reduction of foetal liver
glycogen by glycogenolysis. In normal foetal rats, the
insulin/glucagpn ratio decreased during the last 2—3
days of gestation (6, 8, 9). However, at the same
time, the liver glycogen content increases considera-
bly (5, 8, 9). Therefore, the regulation of glycogen in
foetal liver seems to be more complicated, becaüse
of the involvement of other components e.g. Ca2+,
hormone receptors, adenylate cyclase, cAMP-phos-
phodiesterase, glycogensynthetase, phosphorylase,
phosphorylase phosphatase, synthetase phosphatase
(10). Their catalytic activities change during foetal
development (8, 9), and their kinetic properties are
different from the enzymes in adult liver (8), al-
though they have not been defined in detail.
Thus, the precocious glycogenolysis after Mg2+-
treatment, may result from an enhanced reduction of
the insülin/glucagon ratio.
An altered extracellular Mg2+/Ca2+-competition at
the islet cell membrane is a possible explanation for
an altered foetal hormone secretion. When pancrea-
tic islets (from adult animals) were incubated with
increased Mg2+-concentration at constant Ca2+-con-
centration, insulin secretion was decreased (11, 12),
although this effect was only significant at rather
high Mg2"l"-concentration (11, 12). However, it is not
known whether insulin and glucagon secretion of
foetal pancreatic islets shows the same sensitivity to
increased extracellular Mg2+ äs in the adult pan-
creas.
As glucose-6-phosphatase is bound to ER, the en-
hanced development of this organeile after Mg2+-
treatment may be evidence for increased glycogeno-
lysis by another mechanism. This enzyme, inducible
by glucagon (8), can reduce the glucose-6-phosphate
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concentration. As glucose-6-phosphate is an alloste-
ric activator of glycogen synthetase, a precocious de-
crease in glucose-6-phosphate may be responsible
for a lower synthesis of glycogen and thus a preco-
cious decrease in glycogen content.
However, other enzymes, regulating synthesis and
degradation of glycogen may be also changed by the
Mg2+-treatment. Moreover, MgCl2-treatment may
change the concentration of intracellular free Ca2+,
which is also involved in glycogen metabolism (10).
Because of the very low cytosolic Ca2+ concentration
and strong compartmentalization, the partidpation
of Ca2+ cannot be determined by measuring the total
Ca2+ content of the liver. More experiments are
needed to clarify the regulatofy rnechanisms of gly-
cogen metabolism in normal and Mg^-treated foetal
livers. The enhanced development of excretory pan-
creas may be related to the enhanced development
of its ER. The mechanism may !be simiiar to the in-
crease of ER in the foetal liver after Mg2+-tfeat-
ment.
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